Creative Planning
GTHX

Creative Planning’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Creative Planning’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,609
Closed -$255K – 2652
2021
Q1 		$255K Sell
10,609
-11,257
-51% -$262K ﹤0.01% 1902
2020
Q4 		$393K Buy
+21,866
New +$327K ﹤0.01% 1457

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Creative Planning's GTHX Position: Q2 2021 in Review

Creative Planning sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2021, closing a stake of 10,609 shares — an estimated $255K sold.

Creative Planning first reported a position in GTHX in Q4 2020 and held it in 2 quarters. The position peaked at $393K in Q4 2020. 114 funds tracked by Wall St. Rank hold GTHX as of Q2 2021.

  • Creative Planning reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Creative Planning sold 10,609 G1 Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $255K.
  • Creative Planning first reported a position in G1 Therapeutics, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
  • Creative Planning's G1 Therapeutics, Inc. Common Stock position peaked at $393K in Q4 2020.
  • 114 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Creative Planning's 13F filing for Q2 2021, filed 4 Aug 2021.